|
| RENAL DATA FROM THE ASIA - AFRICA |
 |
|
|
| Year : 2021 |
Volume
: 32 | Issue : 6 | Page
: 1764-1774 |
|
Acute Kidney Injury and Mortality among Patients with Coronavirus Disease-2019 in Pakistan
Raheel Ahmed1, Khaola Fazle Maula2, Zahid Ali3, Mohammad Ismail3, Inayat Ur Rehman4, Sedra Fazle Maula5, Samina Masood Ali6, Tahir Mehmood Khan7
1 Department of Nephrology and Renal Transplantation, Institute of Kidney Diseases Hayatabad, Peshawar, Pakistan
2 Department of Obstetrics and Gynecology, Hayatabad Medical Complex, Peshawar, Pakistan
3 department of Pharmacy, University of Peshawar, Peshawar, Pakistan
4 Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan
5 Department of Pediatrics, Hayatabad Medical Complex, Peshawar, Pakistan
6 Department of Radiology, Institute of Kidney Diseases Hayatabad, Peshawar, Pakistan
7 Institute of Pharmaceutical Sciences, University of Veterinary and Animal Science, Outfall Campus, Civil Lines, Lahore, Pakistan; School of Pharmacy, Monash University, Jalan Lagoon Selatan, Bandar Sunway, Selangor, Malaysia, Pakistan
Correspondence Address:
Raheel Ahmed
Department of Nephrology and Renal Transplantation, Institute of Kidney Diseases, Hayatabad, Peshawar, Pakistan.
Pakistan
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-2442.352439
|
|
|
The kidney is the most vulnerable organ in coronavirus disease-2019 (COVID-19) patients besides the lungs, with evidence of acute kidney injury (AKI). We aimed to find the prevalence of AKI among COVID-19 patients and further evaluate the association of between COVID-19 and AKI along with an understanding of mortality. A prospective observational study was conducted among COVID-19 patients admitted to a tertiary care hospital, Hayatabad Medical Complex, between March 2020 and June 2020. Chi-square test was applied for comparative analysis, whereas for predictors of mortality, odds ratios (OR) were calculated using logistic regression. A total of 606 patients with COVID-19 were admitted to the dedicated ward, of which 250 (41.3%) had AKI and 190 (31.4%) died, whereas, patients having AKI presented 62.1% of mortality. Our study revealed a statistically significant association between AKI and mortality (OR = 3.5; P <0.0001). Moreover, we observed a greater risk of deaths among patients with AKI stage I-III i.e., AKI stage I (OR = 2.4; P <0.0001), stage II (OR = 5.5; P = 0.0001), and stage III (OR = 6.6; P<0.0001). Our study reported AKI and associated mortality in a considerable number of patients with COVID-19. AKI patients have significantly higher chances of death versus non-AKI patients. Further, the risk of mortality increases with further deterioration in kidney function, i.e., patients with AKI stage III showed a higher mortality rate compared with stage II and stage I.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
|
|
|
|
| Article Access Statistics | | | Viewed | 368 | | | Printed | 2 | | | Emailed | 0 | | | PDF Downloaded | 30 | | | Comments | [Add] | | |
|
|
